Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.

about

Metastatic retinoblastoma of the parotid and submandibular glands: a rare case report.Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis.

P2860

Q47098196-C80C1564-1A49-4F03-803B-1F92AE2CE71D Q55021792-21A8678A-1277-4D50-B37A-038B01D85847

P2860

Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.

Item

http://www.wikidata.org/entity/Q39395593

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.

@en

Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.

@nl

type

Item

label

Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.

@en

Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.

@nl

prefLabel

Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.

@en

Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.

@nl

P1476

Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.

@en

P2093

Emily Zolfaghari

http://www.w3.org/2001/XMLSchema#string

Jonathan W Kim

http://www.w3.org/2001/XMLSchema#string

Mercy Bechtold

http://www.w3.org/2001/XMLSchema#string

Rima Jubran

http://www.w3.org/2001/XMLSchema#string

Sona Shah

http://www.w3.org/2001/XMLSchema#string

P2860

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials

Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience

Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials

Anterior Ocular Toxicity of Intravitreous Melphalan for Retinoblastoma.

Intraocular retinoblastoma: the case for a new group classification.

Chemotherapy plus local treatment in the management of intraocular retinoblastoma.

Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy.

Intravitreal Lower-Dose (20 µg) Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds.

Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy.

P31

scholarly article

P356

10.1002/PBC.26696

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jesse L Berry

P577

2017-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28646513

http://www.w3.org/2001/XMLSchema#string

P921

retinoblastoma

Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.

about

P2860

P2860

Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921